Holen Sie sich die Stockscreener-App
42.85
0.28%
-0.11
Handel nachbörslich:
42.85
Schlusskurs vom Vortag:
$42.96
Offen:
$42.29
24-Stunden-Volumen:
1.26M
Relative Volume:
1.32
Marktkapitalisierung:
$3.27B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.16M
KGV:
-33.73
EPS:
-1.2702
Netto-Cashflow:
$-69.06M
1W Leistung:
+12.74%
1M Leistung:
+28.49%
6M Leistung:
+113.56%
1J Leistung:
+14.18%
1-Tages-Spanne:
$41.54
$43.52
1-Wochen-Bereich:
$38.50
$45.56
52-Wochen-Spanne:
$14.80
$45.56
Cg Oncology Inc Stock (CGON) Company Profile
Firmenname
Cg Oncology Inc
Sektor
Branche
Telefon
(949) 419-6203
Adresse
400 SPECTRUM CENTER DRIVE, IRVINE
Vergleichen Sie CGON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
42.85 | 3.28B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-08 | Eingeleitet | Guggenheim | Buy |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-05-02 | Eingeleitet | JP Morgan | Overweight |
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Perform |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-09-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-28 | Eingeleitet | ROTH MKM | Buy |
| 2024-06-28 | Eingeleitet | BofA Securities | Buy |
| 2024-02-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Eingeleitet | Goldman | Neutral |
| 2024-02-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-14 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cg Oncology Inc Aktie (CGON) Neueste Nachrichten
Why CG Oncology Inc. stock is rated strong buyQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Short interest data insights for CG Oncology Inc.July 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com
Why retail investors favor CG Oncology Inc. stockLayoff News & Accurate Buy Signal Notifications - newser.com
How to recover losses in CG Oncology Inc. stockJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
James Mulay Sells 5,903 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
CG Oncology (NASDAQ:CGON) Research Coverage Started at Guggenheim - Defense World
CG Oncology (CGON) Is Up 8.6% After Analysts Spotlight Late-Stage Bladder Cancer Therapy Data – Has the Bull Case Changed? - Sahm
Midday Stock Roundup: EnVVeno down 15% - Orange County Business Journal
CG Oncology (NASDAQ:CGON) Reaches New 1-Year HighHere's What Happened - MarketBeat
CG Oncology (NASDAQ:CGON) Now Covered by Analysts at Guggenheim - MarketBeat
Is this a good reentry point in CG Oncology Inc.2025 Institutional Moves & Fast Gaining Stock Strategy Reports - newser.com
Candlestick signals on CG Oncology Inc. stock todayJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
CG Oncology (NASDAQ:CGON) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results - Yahoo Finance
CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? (NASDAQ:CGON) - Seeking Alpha
CG Oncology’s Surging Prospects: Buy or Hold? - StocksToTrade
When is the best time to exit CG Oncology Inc.Stop Loss & Expert Verified Movement Alerts - newser.com
CG Oncology Inc. recovery potential after sell offJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
CG Oncology (CGON): Valuation in Focus After Analyst Coverage and Promising Cretostimogene Phase 3 Results - Sahm
Price momentum metrics for CG Oncology Inc. explainedJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Ranking CG Oncology Inc. among high performing stocks via toolsLong Setup & Accurate Entry/Exit Alerts - newser.com
Why Cg Oncology Stock Rocketed 7% Higher Today - The Globe and Mail
Why Cg Oncology Stock Rocketed 7% Higher Today - The Motley Fool
CG Oncology (NASDAQ:CGON) Trading 7.1% HigherHere's What Happened - MarketBeat
CG Oncology stock initiated Buy at Guggenheim (CGON:NASDAQ) - Seeking Alpha
Guggenheim Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage on CG Oncology With Buy Rating, $90 Price Target - MarketScreener
CG Oncology, Inc. (CGON) Stock Analysis: 73% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
CG Oncology Announces Promising Phase 3 Trial Results - MSN
Applying Elliott Wave Theory to CG Oncology Inc.Portfolio Profit Report & Verified Swing Trading Watchlists - newser.com
What’s next for CG Oncology Inc. stock priceProduct Launch & High Return Trade Opportunity Guides - newser.com
How CG Oncology Inc. stock reacts to bond yieldsQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
How to monitor CG Oncology Inc. with trend dashboardsJuly 2025 Update & Safe Entry Point Alerts - newser.com
Will a bounce in CG Oncology Inc. offer an exitJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
How analysts rate CG Oncology Inc. stock today2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
CG Oncology (NASDAQ:CGON) Upgraded to Hold at Wall Street Zen - Defense World
CG Oncology (NASDAQ:CGON) Raised to "Hold" at Wall Street Zen - MarketBeat
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Best data tools to analyze CG Oncology Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Can you recover from losses in CG Oncology Inc.2025 Technical Overview & Fast Entry High Yield Stock Tips - newser.com
AMI Asset Management Corp Purchases New Stake in CG Oncology, Inc. $CGON - MarketBeat
Finanzdaten der Cg Oncology Inc-Aktie (CGON)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):